U.S EYES GIVING EMERGENCY APPROVAL TO COVID-19 VACCINE
Stephen Hahn, the head of the US Food and Drug Administration, has raised the possibility of giving an emergency approval on coronavirus vaccines being developed in the country, even before trials are concluded.
“If they do that before the end of Phase Three,” which involves large-scale human testing, “we may find that appropriate. We may find that inappropriate. We will make a determination,” Hahn said.
The move has drawn criticism that he is giving in to the Trump administration’s pressure to step up the production of a vaccine ahead of the November 3 elections.
The US has reported almost six million cases and 183,000 deaths, raising criticism and questions against the Trump administration’s handling of the deadly pandemic.